Assignee
CSTONE PHARMACEUTICALS SUZHOU CO LTD
CN·3 granted patents·1 pending application·8 citations·filing 2018–2020
Top patents by PatentIndex Score
4 records- 0188US10745389B2HDAC6 selective inhibitors, preparation method therefor, and application thereofCSTONE PHARMACEUTICALS (SUZHOU) CO LTD·Filed 2018·Granted Aug 18, 2020·6 cites·17 claims
- 0272US11312715B2Fused ring derivative as A2A receptor inhibitorCSTONE PHARMACEUTICALS SUZHOU CO LTD·Filed 2018·Granted Apr 26, 2022·2 cites·18 claims
- 0358US11345682B2Polymorph of HDAC6-selective inhibitor and application thereofCSTONE PHARMACEUTICALS SUZHOU CO LTD·Filed 2019·Granted May 31, 2022·0 cites·8 claims
- 0452US2022387417A1Pharmaceutical Combination and Use ThereofCSTONE PHARMACEUTICALS SUZHOU CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CSTONE PHARMACEUTICALS SUZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →